ImmunoPrecise Antibodies
Quarterly Financials
| Values in thousands | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|
Revenue | $3,161 | $6,981 | $6,151 | $6,125 |
Gross Profit | 1,527 | 4,460 | 3,295 | 3,437 |
EBITDA | -988 | -22,967 | -1,524 | |
EBIT | -1,901 | -24,363 | -2,929 | |
Net Income | -2,959 | -2,161 | -21,521 | -2,553 |
Net Change In Cash | 3,161 | 6,981 | 6,151 | 6,125 |
Free Cash Flow | -4,495 | -1,499 | -1,315 | -2,308 |
Cash | 4,897 | 10,665 | 12,915 | 3,534 |
Basic Shares | 46,154 | 33,118 | 32,851 | 28,132 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $24,520 | $24,518 | $20,665 | $19,364 |
Gross Profit | 13,548 | 12,053 | 11,563 | 10,983 |
EBITDA | -28,855 | -22,949 | -21,037 | -11,994 |
EBIT | -33,974 | -28,684 | -27,722 | -15,763 |
Net Income | -30,234 | -27,177 | -26,560 | -16,709 |
Net Change In Cash | 24,520 | 24,518 | 20,665 | 19,364 |
Free Cash Flow | -7,209 | -5,643 | -21,328 | -11,178 |
Cash | 10,665 | 3,459 | 8,280 | 29,965 |
Basic Shares | 33,385 | 25,636 | 24,897 | 19,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-07-31 | -$0.04 |
2025-04-30 | -$0.03 |
2025-01-31 | -$0.46 |
2024-10-31 | -$0.06 |
